Nutritional Status Among Upper Gastrointestinal Cancer Patients Upon Admission (RSCH ID-22-012)

May 18, 2023 updated by: ChiouYi Ho, Universiti Putra Malaysia
Cross-sectional study. Data on clinical, anthropometric, biochemical profile and dietary intake Upper Gastrointestinal Cancer Patients upon admission are traced and collected.

Study Overview

Status

Completed

Conditions

Detailed Description

As per routine care, on the day of admission, nutrition assessment and clinical examination of all in-patients will be carried out. Patient screening will be done by assigned investigator based on the dietitian censes based on inclusion and exclusion criteria. The investigator will trace the data from medical system and record in the data collection form.

Study Type

Observational

Enrollment (Actual)

409

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Malaysia
      • Putrajaya, Malaysia, 62250
        • Institut Kanser Negara (National Cancer Institute)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

histologically confirmed Upper Gastrointestinal Cancers

Description

Inclusion Criteria:

  • Admitted UGIC patient
  • Seen by dietitian in ward

Exclusion Criteria:

  • Not admitted in ward
  • Aged <18 years old
  • Non-Malaysian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
nutrition assessment
Time Frame: within 2 hours upon admission
anthropometry (weight)
within 2 hours upon admission
nutrition assessment
Time Frame: within 24 hours upon admission
dietary assessment
within 24 hours upon admission
nutrition assessment
Time Frame: within 24 hours upon admission
nutrition impact symptom (NIS)
within 24 hours upon admission
nutrition assessment
Time Frame: within 24 hours upon admission
subjective global assessment (SGA)
within 24 hours upon admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemical data
Time Frame: within 2 hours upon admission
albumin
within 2 hours upon admission
Biochemical data
Time Frame: within 2 hours upon admission
lymphocytes
within 2 hours upon admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universiti Putra Malaysia

Collaborators

National Cancer Institute, Malaysia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

May 31, 2022

Study Completion (Actual)

March 31, 2023

Study Registration Dates

First Submitted

May 10, 2023

First Submitted That Met QC Criteria

May 18, 2023

First Posted (Actual)

May 22, 2023

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 18, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NMRR ID-22-00792-HKU
  • RSCH ID-22-01272-6KC (Other Identifier: Ministry of Health Medical Research and Ethics Committee (MREC))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nutritional Status

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe